© CNRS Images - 2016
As a 2016 CNRS Innovation Medal laureate, Thierry Heidmann looks back on his career. As a specialist of infectious and endogenous retroviruses in animals and humans, the researcher has been investigating their immunosuppressive properties and has contributed to opening up new therapeutic strategies. Heidmann is the director of the research unit on the molecular physiology and pathology of endogenous and infectious retroviruses at the Gustave Roussy Institute in Villejuif and he also founded a start-up, Viroxis, in 2005 and is an inventor of six awarded patents. His research work led to new vaccine candidates targeting these pathogens, including one against the Feline leukaemia virus, which has been available on the market since 2012.